A half-billion dollars later, Peninsula company goes SPAC route to roll out its AI-based heart test
The "blank-check" merger will create a company with $400 million to expand uptake of its heart disease test, save money for health care providers and lead to better diagnosis and treatment for patients.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Cardiology | Health Management | Heart | Heart Disease | Mergers and Aquisitions